Abstract
To begin to define the role of granulocyte colony-stimulating factor (G-CSF) in the regulation of hematopoiesis, Lieschke and colleagues generated G-CSF−/− (knockout) mice [1]. Knockout mice are genetically engineered to contain a complete loss-of-function (null) mutation of the gene of interest. They are generated by homologous recombination in murine embryonic stem cells in which the normal gene (in this case Csf3 encoding G-CSF) is replaced with a mutated gene. The targeted embryonic stem cells are implanted into pseudopregnant mice to generate a transgenic mouse line carrying the mutated gene. Importantly, the rest of the murine genome is intact, allowing investigators to examine the effect of the loss of that gene, in isolation, on a biologic process.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lieschke GJ, Grail D, Hodgson G et al (1994) Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84:1737–1746
Liu F, Wu HY, Wesselschmidt R, Kornaga T, Link DC (1996) Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity 5:491–501
Walker F, Zhang HH, Matthews V et al (2008) IL6/sIL6R complex contributes to emergency granulopoietic responses in G-CSF- and GM-CSF-deficient mice. Blood 111:3978–3985
Seymour JF, Lieschke GJ, Grail D, Quilici C, Hodgson G, Dunn AR (1997) Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long-term survival. Blood 90:3037–3049
Dalrymple SA, Lucian LA, Slattery R et al (1995) Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect Immun 63:2262–2268
Romani L, Mencacci A, Cenci E et al (1996) Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J Exp Med 183:1345–1355
Liu F, Poursine-Laurent J, Wu HY, Link DC (1997) Interleukin-6 and the granulocyte colony-stimulating factor receptor are major independent regulators of granulopoiesis in vivo but are not required for lineage commitment or terminal differentiation. Blood 90:2583–2590
Kaushansky K, Fox N, Lin NL, Liles WC (2002) Lineage-specific growth factors can compensate for stem and progenitor cell deficiencies at the postprogenitor cell level: an analysis of doubly TPO- and G-CSF receptor-deficient mice. Blood 99:3573–3578
Quinton LJ, Nelson S, Boe DM et al (2002) The granulocyte colony-stimulating factor response after intrapulmonary and systemic bacterial challenges. J Infect Dis 185:1476–1482
Kawakami M, Tsutsumi H, Kumakawa T et al (1990) Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood 76:1962–1964
Basu S, Hodgson G, Zhang HH, Katz M, Quilici C, Dunn AR (2000) “Emergency” granulopoiesis in G-CSF-deficient mice in response to Candida albicans infection. Blood 95:3725–3733
Zhan Y, Lieschke GJ, Grail D, Dunn AR, Cheers C (1998) Essential roles for granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF in the sustained hematopoietic response of Listeria monocytogenes-infected mice. Blood 91:863–869
Gregory AD, Hogue LA, Ferkol TW, Link DC (2007) Regulation of systemic and local neutrophil responses by G-CSF during pulmonary Pseudomonas aeruginosa infection. Blood 109:3235–3243
Dong F, van Buitenen C, Pouwels K, Hoefsloot LH, Lowenberg B, Touw IP (1993) Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation. Mol Cell Biol 13:7774–7781
Yoshikawa A, Murakami H, Nagata S (1995) Distinct signal transduction through the tyrosine containing domains of the granulocyte colony-stimulating factor receptor. EMBO 14:5288–5296
Semerad CL, Christopher MJ, Liu F et al (2005) G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 106:3020–3027
Stoffel R, Ziegler S, Ghilardi N, Ledermann B, de Sauvage FJ, Skoda RC (1999) Permissive role of thrombopoietin and granulocyte colony-stimulating factor receptors in hematopoietic cell fate decisions in vivo. Proc Natl Acad Sci U S A 96:698–702
Jacob J, Haug JS, Raptis S, Link DC (1998) Specific signals generated by the cytoplasmic domain of the granulocyte colony-stimulating factor (G-CSF) receptor are not required for G-CSF-dependent granulocytic differentiation. Blood 92:353–361
Yang FC, Tsuji K, Oda A et al (1999) Differential effects of human granulocyte colony-stimulating factor (hG-CSF) and thrombopoietin on megakaryopoiesis and platelet function in hG-CSF receptor-transgenic mice. Blood 94:950–958
Richards MK, Liu F, Link DC (2001) G-CSF receptor signals may play a pivotal role in directing commitment to the common myeloid lineage. Blood 98:795a
O’Grady NP, Preas HL, Pugin J et al (2001) Local inflammatory responses following bronchial endotoxin instillation in humans. Am J Respir Crit Care Med 163:1591–1598
de Haas M, Kerst JM, van der Schoot CE et al (1994) Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of the immediate activating effects on circulating neutrophils. Blood 84:3885–3894
Hoglund M, Hakansson L, Venge P (1987) Effects of in vivo administration of G-CSF on neutrophil functions in healthy volunteers. Eur J Haematol 58:195–202
Yuo A, Kitagawa S, Ohsaka A et al (1989) Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence. Blood 74:2144–2149
Yong KL (1996) Granulocyte colony-stimulating factor (G-CSF) increases neutrophil migration across vascular endothelium independent of an effect on adhesion: comparison with granulocyte-macrophage colony-stimulating factor (GM-CSF). Br J Haematol 94:40–47
Metcalf D, Robb L, Dunn AR, Mifsud S, Di Rago L (1996) Role of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in the development of an acute neutrophil inflammatory response in mice. Blood 88:3755–3764
Betsuyaku T, Liu F, Senior RM et al (1999) A functional granulocyte colony-stimulating factor receptor is required for normal chemoattractant-induced neutrophil activation. J Clin Invest 103:825–832
Eyles JL, Hickey MJ, Norman MU et al (2008) A key role for G-CSF-induced neutrophil production and trafficking during inflammatory arthritis. Blood 112:5193–5201
McKinstry WJ, Li CL, Rasko JE, Nicola NA, Johnson GR, Metcalf D (1997) Cytokine receptor expression on hematopoietic stem and progenitor cells. Blood 89:65–71
Zandstra PW, Conneally E, Petzer AL, Piret JM, Eaves CJ (1997) Cytokine manipulation of primitive human hematopoietic cell self-renewal. Proc Natl Acad Sci U S A 94:4698–4703
Gibbs KD Jr, Gilbert PM, Sachs K et al (2011) Single-cell phospho-specific flow cytometric analysis demonstrates biochemical and functional heterogeneity in human hematopoietic stem and progenitor compartments. Blood 117(16):4226–4233
Rosenberg PS, Alter BP, Link DC et al (2008) Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia. Br J Haematol 140:210–213
Link DC, Kunter G, Kasai Y et al (2007) Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia. Blood 110:1648–1655
Bernard T, Gale RE, Linch DC (1996) Analysis of granulocyte colony stimulating factor receptor isoforms, polymorphisms and mutations in normal haemopoietic cells and acute myeloid leukaemia blasts. Br J Haematol 93:527–533
Carapeti M, Soede-Bobok A, Hochhaus A et al (1997) Rarity of dominant-negative mutations of the G-CSF receptor in patients with blast crisis of chronic myeloid leukemia or de novo acute leukemia. Leukemia 11:1005–1008
Dong F, Brynes RK, Tidow N, Welte K, Lowenberg B, Touw IP (1995) Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med 333:487–493
Germeshausen M, Ballmaier M, Welte K (2007) Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: results of a long-term survey. Blood 109:93–99
Hermans MH, Ward AC, Antonissen C, Karis A, Lowenberg B, Touw IP (1999) Perturbed granulopoiesis in mice with a targeted mutation in the granulocyte colony-stimulating factor receptor gene associated with severe chronic neutropenia. Blood 92:32–39
McLemore ML, Poursine-Laurent J, Link DC (1998) Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia. J Clin Invest 102:483–492
van de Geijn GJ, Gits J, Aarts LH, Heijmans-Antonissen C, Touw IP (2004) G-CSF receptor truncations found in SCN/AML relieve SOCS3-controlled inhibition of STAT5 but leave suppression of STAT3 intact. Blood 104:667–674
Hermans MH, Antonissen C, Ward AC, Mayen AE, Ploemacher RE, Touw IP (1999) Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia/acute myeloid leukemia-derived mutation in the G-CSF receptor gene. J Exp Med 189:683–692
Ancliff PJ, Gale RE, Liesner R, Hann I, Linch DC (2003) Long-term follow-up of granulocyte colony-stimulating factor receptor mutations in patients with severe congenital neutropenia: implications for leukaemogenesis and therapy. Br J Haematol 120:685–690
Germeshausen M, Ballmaier M, Welte K (2009) In vivo growth advantage of cells expressing acquired CSF3R mutations in patients with severe congenital neutropenia. Blood 113:668–670
Liu F, Kunter G, Krem MM et al (2008) Csf3r mutations in mice confer a strong clonal HSC advantage via activation of Stat5. J Clin Invest 118:946–955
McLemore ML, Grewal S, Liu F et al (2001) STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation. Immunity 14:193–204
Stem Cell Trialists’ Collaborative Group (2005) Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. J Clin Oncol 23:5074–5087
Demetri GD, Griffin JD (1991) Granulocyte colony-stimulating factor and its receptor. Blood 78:2791–2808
Bussolino F, Ziche M, Wang JM et al (1991) In vitro and in vivo activation of endothelial cells by colony-stimulating factors. J Clin Invest 87:986–995
Liu F, Poursine-Laurent J, Link DC (1997) The granulocyte colony-stimulating factor receptor is required for the mobilization of murine hematopoietic progenitors into peripheral blood by cyclophosphamide or interleukin-8 but not flt-3 ligand. Blood 90:2522–2528
Christopher MJ, Rao M, Liu F, Woloszynek JR, Link DC (2011) Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice. J Exp Med 208:251–260
Chow A, Lucas D, Hidalgo A et al (2011) Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J Exp Med 208:261–271
Winkler IG, Sims NA, Pettit AR et al (2010) Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood 116:4815–4828
Kollet O, Dar A, Shivtiel S et al (2006) Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med 12:657–664
Takamatsu Y, Simmons PJ, Moore RJ, Morris HA, To LB, Levesque J-P (1998) Osteoclast-mediated bone resorption is itimulated during short-term administration of granulocyte colony-stimulating factor but is not responsible for hematopoietic progenitor cell mobilization. Blood 92:3465–3473
Kiel MJ, Yilmaz OH, Iwashita T, Terhorst C, Morrison SJ (2005) SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121:1109–1121
Sugiyama T, Kohara H, Noda M, Nagasawa T (2006) Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25:977–988
Yoshimoto M, Shinohara T, Heike T, Shiota M, Kanatsu-Shinohara M, Nakahata T (2003) Direct visualization of transplanted hematopoietic cell reconstitution in intact mouse organs indicates the presence of a niche. Exp Hematol 31:733–740
Nilsson SK, Johnston HM, Coverdale JA (2001) Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. Blood 97:2293–2299
Lo Celso C, Fleming HE, Wu JW et al (2009) Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature 457:92–96
Xie Y, Yin T, Wiegraebe W et al (2009) Detection of functional haematopoietic stem cell niche using real-time imaging. Nature 457:97–101
Calvi LM, Adams GB, Weibrecht KW et al (2003) Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425:841–846
Zhang J, Niu C, Ye L et al (2003) Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425:836–841
Visnjic D, Kalajzic Z, Rowe DW, Katavic V, Lorenzo J, Aguila HL (2004) Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood 103:3258–3264
Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC (1997) The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 185:111–120
Wright DE, Bowman EP, Wagers AJ, Butcher EC, Weissman IL (2002) Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J Exp Med 195:1145–1154
Nagasawa T, Hirota S, Tachibana K et al (1996) Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382:635–638
Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR (1998) Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393:595–599
Ma Q, Jones D, Springer TA (1999) The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 10:463–471
Christopher MJ, Liu F, Hilton MJ, Long F, Link DC (2009) Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization. Blood 114:1331–1339
Broxmeyer HE, Kohli L, Kim CH et al (2003) Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and G(alpha)i proteins and enhances engraftment of competitive, repopulating stem cells. J Leukoc Biol 73:630–638
Liles WC, Broxmeyer HE, Rodger E et al (2003) Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 102:2728–2730
Froberg MK, Garg UC, Stroncek DF, Geis M, McCullough J, Brown DM (1999) Changes in serum osteocalcin and bone-specific alkaline phosphatase are associated with bone pain in donors receiving granulocyte-colony-stimulating factor for peripheral blood stem and progenitor cell collection. Transfusion 39:410–414
Katayama Y, Battista M, Kao WM et al (2006) Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 124:407–421
Mayack SR, Wagers AJ (2008) Osteolineage niche cells initiate hematopoietic stem cell mobilization. Blood 112:519–531
Nervi B, Ramirez P, Rettig MP et al (2009) Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100. Blood 113:6206–6214
Acknowledgments
DCL is supported by grants from the NIH (RO1 CA136617; RC2 CA1455073; and RO1 HL60772) and by the Leukemia & Lymphoma Society TRA 6030-10). The author thanks Mahil Rao for the generation of Fig. 3.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Basel AG
About this chapter
Cite this chapter
Link, D.C. (2012). Mouse Models of G-CSF Signaling in Hematopoiesis. In: Molineux, G., Foote, M., Arvedson, T. (eds) Twenty Years of G-CSF. Milestones in Drug Therapy. Springer, Basel. https://doi.org/10.1007/978-3-0348-0218-5_3
Download citation
DOI: https://doi.org/10.1007/978-3-0348-0218-5_3
Published:
Publisher Name: Springer, Basel
Print ISBN: 978-3-0348-0217-8
Online ISBN: 978-3-0348-0218-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)